Thanks for clarifying. Further to this comment from [0]: "But with Cfp1, the stakes of that specific patent dispute go down. A lab or company could use Cfp1 w

Thanks for clarifying. Further to this comment from [0]: "But with Cfp1, the stakes of that specific patent dispute go down. A lab or company could use Cfp1 without infringing on the CRISPR/Cas9 patent. " [0] http://www.wired.com/2015/09/war-genome-editing-just-got-lot-interesting/?mbid=social_twitter http://www.wired.com/2015/09/war-genome-editing-just-got-lot...